Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “benzoic acid”

62 pharma patents match "benzoic acid" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 62
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 62 pharmaceutical patents matching "benzoic acid" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

62 results for “benzoic acid” · 30,257 patents in full index Clear search

  1. US 8975287

    Methods for using 1,2,4-Oxadiazole benzoic acid compounds

    PTC THERAPEUTICS, INC. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted

  2. US 8969574

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  3. US 8846718

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  4. US 8796322

    Methods for using 1,2,4-oxadiazole benzoic acid compounds

    PTC THERAPEUTICS, INC. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  5. US 8748625

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  6. US 8742122

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  7. US 8716338

    Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted May 6, 2014 · Expires May 1, 2034

    granted

  8. US 8691511

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  9. US 8653103

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  10. US 8592602

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  11. US 8552034

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  12. US 8536165

    Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

    Almirall, S.A. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  13. US 8507534

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  14. US 8507687

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  15. US 8501943

    Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor

    Almirall, S.A. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  16. US 8486982

    1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  17. US 8394966

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  18. US 8367841

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  19. US 8334313

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  20. US 8299105

    1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  21. US 8227494

    Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  22. US 8163782

    1,2,4-oxadiazole benzoic acid compositions

    PTC THERAPEUTICS, INC. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  23. US 8129540

    Methods for the synthesis of 1,2,4-oxadiazole benzoic acid compounds

    PTC THERAPEUTICS, INC. · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted

  24. US 8124781

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.